Answers are grounded in this paper and cite their sources.
J-LN syndrome is a most severe variant of LQTS, with a very early onset and major QTc prolongation, and in which beta-blockers have limited efficacy. Subgroups at relatively lower risk for CA/SD are identifiable and include females, patients with a QTc < or =550 ms, those without events in the first year of life, and those with mutations on KCNE1. Early therapy with implanted cardioverter/defibrillators must be considered.
No takes yet. Share an insight, caveat, or question.
Schwartz et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: